Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2019)
Pacira BioSciences (PCRX) recorded quarterly Other Non-Current Assets of $560000.0 in Q1 2019, down 14.76% quarter-over-quarter from $657000.0 in Q4 2018, and down 26.22% on a YoY basis from $759000.0 in Q1 2018.
Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2019) Analysis & Trends
Pacira BioSciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $560000.0 for Q1 2019.
- In Q1 2019, Other Non-Current Assets fell 26.22% year-over-year to $560000.0; the TTM figure through Mar 2019 stood at $560000.0 (down 26.22% YoY), while the FY2018 annual figure was $657000.0, down 20.36% from the prior year.
- Other Non-Current Assets was $560000.0 for Q1 2019 at Pacira BioSciences, down from $657000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.6 million in Q3 2015 to a low of $406000.0 in Q4 2015.
- Historically, Other Non-Current Assets has averaged $945470.6 across 5 years, with a median of $657000.0 in 2018.
- The sharpest annual moves came in 2015 and 2016: Other Non-Current Assets tumbled 84.31% in 2015, then soared 53.69% in 2016.
- A 5-year view of Other Non-Current Assets shows it stood at $406000.0 in 2015, then soared by 53.69% to $624000.0 in 2016, then jumped by 32.21% to $825000.0 in 2017, then decreased by 20.36% to $657000.0 in 2018, then decreased by 14.76% to $560000.0 in 2019.
- The last three Other Non-Current Assets figures came in at $560000.0 (Q1 2019), $657000.0 (Q4 2018), and $747000.0 (Q3 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Pacira BioSciences | 935.46 Mn | 733.28 Mn | 140.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 560,000.00 |
| Dec 31, 2018 | 657,000.00 |
| Sep 30, 2018 | 747,000.00 |
| Jun 30, 2018 | 692,000.00 |
| Mar 31, 2018 | 759,000.00 |
| Dec 31, 2017 | 825,000.00 |
| Sep 30, 2017 | 545,000.00 |
| Jun 30, 2017 | 572,000.00 |
| Mar 31, 2017 | 598,000.00 |
| Dec 31, 2016 | 624,000.00 |
| Sep 30, 2016 | 651,000.00 |
| Jun 30, 2016 | 677,000.00 |
| Mar 31, 2016 | 481,000.00 |
| Dec 31, 2015 | 406,000.00 |
| Sep 30, 2015 | 2.60 Mn |
| Jun 30, 2015 | 2.25 Mn |
| Mar 31, 2015 | 2.43 Mn |
| Dec 31, 2014 | 2.59 Mn |
| Sep 30, 2014 | 2.95 Mn |
| Jun 30, 2014 | 3.10 Mn |